why choose us

First received: April 03, 2023

Clinical Trial: The Regional Scintigraphic DPD Uptake in Cardiac Transthyretin Amyloidosis.

Study Status: Completed

Recruit Status: RECRUITING

Condition: Transthyretin Amyloidosis

Study Type: OBSERVATIONAL


Official Title: The Comparisons of Regional Scintigraphic DPD Uptake Between Patients With Hereditary and Wild Type Cardiac Transthyretin Amyloidosis

Brief Summary: Cardiac transthyretin (ATTR) amyloidosis is an infiltrative cardiomyopathy with an inexorably progressive clinical course and poor prognosis.The disease is caused by misfolding of the liver-derived precursor protein transthyretin as a result of an acquired wild-type variant (ATTRwt) or as a hereditary mutant variant (ATTRm).Application of single-photon emission computed tomography (SPECT) provides greater anatomic resolution, enabling the assessment of amyloid burden within individual left ventricle segments.This…

Read more